Home
Scholarly Works
Adjuvant trastuzumab for HER2-positive breast...
Journal article
Adjuvant trastuzumab for HER2-positive breast cancer
Authors
Spicer J; Harries M; Ellis P
Journal
The Lancet, Vol. 366, No. 9486,
Publisher
Elsevier
Publication Date
August 20, 2005
DOI
10.1016/s0140-6736(05)67134-6
ISSN
0140-6736
Associated Experts
Peter Ellis
Professor, Faculty of Health Sciences
Visit profile
Labels
Fields of Research (FoR)
32 Biomedical and clinical sciences
42 Health sciences
Medical Subject Headings (MeSH)
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Breast Neoplasms
Chemotherapy, Adjuvant
Female
Humans
Receptor, ErbB-2
Trastuzumab
Erb-b2 Receptor Tyrosine Kinases
View published work (Non-McMaster Users)
View published work (McMaster Users)
Scholarly citations from Dimensions
Contact the Experts team
Get technical help
or
Provide website feedback